Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : an initiative of the Central European Cooperative Oncology Group (CECOG)
o establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and expertise among oncologists in Central and Southeastern Europe (CEE). Methods: We established and implemented a VTB based on the WebEx platform. This allowed for password-protected and secure upload of patient cases to be presented and discussed among colleagues from various oncology centers scattered throughout CEE in order to arrive at a recommendation for further diagnoses and/or treatment. Results: A total of 73 cases from 16 oncology centers located in 11 CEE countries were uploaded by 22 physicians; 71 were discussed over the course of 17 virtual meetings between June 2018 and May 2019 and 12 different kinds of malignant diseases were discussed with lung cancer (46.6%), melanoma (19.2%) and bladder cancer (13.6%) being the most commonly presented tumor entities. Of the discussed patients, 93.3% had stage IV disease at the time of presentation, 62.6% received chemotherapy or targeted treatment and 67.1% were treated with immune checkpoint inhibitors (ICPIs). The most common causes for presentation and discussion of patient cases were related to the use of ICPIs (80%). Conclusion: When the need for expertise exceeds locally available resources, web-based VTBs provide a feasible way to discuss patient cases and arrive at conclusions regarding diagnoses and/or treatment across large geographic distances. Moreover, VTBs provide an innovative way for proper, state-of-the-art management of patients with malignant diseases in times of social distancing and the resulting need for restricted interaction during the current SARS-CoV‑2 (severe acute respiratory syndrome coronavirus type 2) pandemic.
© The Author(s)
2022
2022-03-31 13:10:23
1033
CECOG, Osrednja in jugovzhodna Evropa, nadzorni imunski zaviralci, maligne bolezni
CECOG, Central and Southeastern Europe, immune checkpoint inhibitors, malignant diseases
Springer Nature
Christiane
Thallinger
70
Peter
Berzinec
70
Emina
Bicakcic
70
Adelina
Dan
70
Gabriella
Fabian
70
Laurentia Nicoletta
Gales
70
Cvetka
Grašič-Kuhar
70
Urška
Janžič
70
Marina
Mencinger
70
Christoph
Zielinski
70
UDK
4
616-006
ISSN pri članku
9
0043-5325
DOI
15
10.1007/s00508-022-02016-z
COBISS_ID
3
102525955
s00508-022-02016-z.pdf
1198192
Predstavitvena datoteka
2022-03-31 13:10:28
0
Izvorni URL
2022-03-31 13:10:28